Key Metrics
CiteScore 

3.1
Impact Factor 

< 5
SJR 

Q4Pharmacology

SNIP 

0.84
Recommended pre-submission checks
Powered by 

Topics Covered on In Vivo
In Vivo Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | INT INST ANTICANCER RESEARCH |
| Language | English |
| Frequency | Bi-monthly |
| General Details |
View less
Planning to publish in In Vivo ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in In Vivo
Impact of Intravenous Immunoglobulin on Neuroinflammation Markers in Patients With Electrical Status Epilepticus During Slow Sleep
- 3 Jul 2026
- In Vivo
A Novel Snore Recording Application Demonstrating High Correlation With Two-channel Portable Monitoring for Diagnosing Sleep Apnea Syndrome
- 3 Jul 2026
- In Vivo
Identification of Differentially Expressed Genes in Nonfunctioning Pituitary Adenoma by Transcriptome Analysis
- 30 Jun 2026
- In Vivo
Combined All-trans Retinoic Acid and Rosiglitazone Alleviates Scleroderma Fibrosis by Suppressing the STAT3/Th17 Axis
- 30 Jun 2026
- In Vivo
Adverse Event Profiling and Comparative Analysis of HER2-targeting Antibody\u2013drug Conjugates Using Pharmacovigilance Databases
- 30 Jun 2026
- In Vivo
Real-world Implementation of Adjuvant Pembrolizumab for High-risk Clear-cell Renal Cell Carcinoma After Surgery
- 30 Jun 2026
- In Vivo
Impact of Intravenous Immunoglobulin on Neuroinflammation Markers in Patients With Electrical Status Epilepticus During Slow Sleep
- 3 Jul 2026
- In Vivo
A Novel Snore Recording Application Demonstrating High Correlation With Two-channel Portable Monitoring for Diagnosing Sleep Apnea Syndrome
- 3 Jul 2026
- In Vivo
Identification of Differentially Expressed Genes in Nonfunctioning Pituitary Adenoma by Transcriptome Analysis
- 30 Jun 2026
- In Vivo
Combined All-trans Retinoic Acid and Rosiglitazone Alleviates Scleroderma Fibrosis by Suppressing the STAT3/Th17 Axis
- 30 Jun 2026
- In Vivo
Adverse Event Profiling and Comparative Analysis of HER2-targeting Antibody\u2013drug Conjugates Using Pharmacovigilance Databases
- 30 Jun 2026
- In Vivo
Real-world Implementation of Adjuvant Pembrolizumab for High-risk Clear-cell Renal Cell Carcinoma After Surgery
- 30 Jun 2026
- In Vivo